Rheinmetall is taking its battlefield autonomy know-how where no Panzer has gone before. The German defence group’s Canadian subsidiary Provectus Robotics Solutions is teaming up with Mission Control to develop a Lunar Utility Rover for the Canadian Space Agency, the company announced on 3 July 2026. At the core sits Rheinmetall’s PATH system, a guidance, navigation and control architecture previously confined to military hardware. Now it is being retooled for the Moon’s surface — a rare crossover between civilian space exploration and rugged defence engineering that fits neatly into the group’s dual-use strategy.
Yet the very week Rheinmetall touted its extraterrestrial ambitions, the ground beneath its domestic business shifted. Late June saw Berlin’s defence ministry cancel the multi-billion-euro F126 frigate programme, awarding the contract to rival TKMS instead. Rheinmetall now calculates the damage: revenue could shrink by up to €300 million this year alone. The blow came as a stark reminder that diversification, however imaginative, cannot fully insulate the company from the stop-start rhythm of German procurement.
The cancellation has also scrambled the order intake outlook. Management had previously guided for new orders around the €20 billion mark for the full year, but the second quarter is now expected to land only in the “low double-digit billion” range — a conspicuous gap that leaves analysts wrestling with the numbers.
JPMorgan’s David H Perry cut his price target from €1,500 to €1,350, keeping a “Neutral” rating. He blamed sluggish government contract awards and noted that defence technology is evolving faster than anticipated, making Rheinmetall’s decade-end goals look “extremely ambitious”. Over at Barclays, the view is markedly sunnier: the target was trimmed only marginally from €2,035 to €2,000, and the bank remains a buyer, forecasting 59% revenue growth in the second quarter.
Should investors sell immediately? Or is it worth buying Rheinmetall?
Investors, however, are yet to be convinced. Rheinmetall shares closed Friday at €1,097.00, down 0.51% on the day but still logging a 16.63% weekly gain. The longer picture is far less rosy: a 30-day slide of 8.02% and a year-to-date drop of 31.50%. The stock trades 45.01% below its 52-week high of €1,995.00 set last September, though it has clawed back 21.55% from the trough of €902.50 touched on 25 June 2026. Annualised volatility stands at a hefty 69.10%, while the RSI of 46.5 points to neutral territory.
Against this choppy backdrop, Rheinmetall also sealed a fresh contract in a very earthly domain: Morocco has ordered seven highly mobile field hospitals, with a value in the mid-double-digit million euro range and deliveries pencilled in for 2027 and 2028. The news, like the moon rover project, underscores the group’s push beyond pure armaments.
The real reckoning comes on 6 August, when Rheinmetall publishes its second-quarter numbers. The frigate cancellation accounted for less than 3% of the long-term forecast, the company has stressed. Investors will soon judge whether that defence holds water — and whether projects from the lunar surface to North African field hospitals can fill the gap where a naval programme once stood.
Ad
Rheinmetall Stock: Buy or Sell?! New Rheinmetall Analysis from July 5 delivers the answer:
The latest Rheinmetall figures speak for themselves: Urgent action needed for Rheinmetall investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from July 5.
Rheinmetall: Buy or sell? Read more here...
